Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment options. A team of...
Organoids are a pioneering tool in biomedical research. These tiny, organ-like cell structures are grown from stem cells and open up completely new possibilities for studying infectious diseases in human tissue. In this...
Scientists at the Helmholtz Centre for Infection Research (HZI) are studying important mechanisms for the development of infectious diseases and how they can be treated or prevented. Some of the research questions can...
The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in Nature Medicine, the expert committee outlines...
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel mode of action are urgently needed. Researchers at the...
Today, around 60 schoolchildren from grades 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to gain an insight into the work of a modern research institution. They were able to immerse...
On March 17 and 18, 2025, the kick-off meeting of the INFRALINK network took place at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Six partner institutions will establish a network to facilitate...
Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom...
An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus....
